Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

TransMedics Group, Inc. (TMDX) Form 8-K — Sep 10, 2026

$TMDXForm 8-KItems 5.02, 7.01, 9.01Filed Sep 10, 2026, 4:40 PM ET0001193125-26-387960Original filing

TransMedics Group appointed Fernando Araujo as Chief Financial Officer and Treasurer effective September 21, 2026, succeeding Gerardo Hernandez, who moves into a Commercial Strategic Advisor role leading the company's Latin America expansion rather than leaving entirely. Araujo brings more than 20 years of public-company finance experience, most recently as CFO of GE HealthCare's $16 billion Advanced Imaging Solutions segment, with prior senior finance roles at 3M and a 17-year tenure at General Electric.

Key figures

Guidance
$737 million to $757 million full-year 2026 revenue, approximately 22% to 25% year-over-year growth
Cfo base salary usd
590000
Cfo signon bonus usd
200000
Ge healthcare segment size
$16 billion
Cfo target bonus pct of base
60
Outgoing cfo base salary usd
535000
Cfo initial rsu award value usd
1750000
Cfo initial option award value usd
1750000

Price after filing

1 day: -3.4%7 days: +1.9%30 days: -8.4%

Close on the filing date to close N calendar days later (from $85.04). Historical, not a forecast.

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    TransMedics Group, Inc. (TMDX) Form 8-K — Sep 10, 2026: AI Analysis | Signal8